Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neoplasms of the CNS
  Free Subscription

Articles published in
PLoS One
    January 2024
  1. AZIMI P, Karimpour M, Yazdanian T, Totonchi M, et al
    Comprehensive somatic mutational analysis in glioblastoma: Implications for precision medicine approaches.
    PLoS One. 2024;19:e0295698.
    >> Share

  2. ZOTEVA V, De Meulenaere V, De Boeck M, Vanhove C, et al
    An improved F98 glioblastoma rat model to evaluate novel treatment strategies incorporating the standard of care.
    PLoS One. 2024;19:e0296360.
    >> Share

  3. BURTON B, Collins K, Brooks J, Marx K, et al
    Correction: The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells.
    PLoS One. 2024;19:e0296579.
    >> Share

  4. LI R, Chen Y, Yang B, Li Z, et al
    Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma.
    PLoS One. 2024;19:e0295346.
    >> Share

  5. WU X, Yang X, Li Z, Liu L, et al
    Multimodal brain tumor image segmentation based on DenseNet.
    PLoS One. 2024;19:e0286125.
    >> Share

  6. BROOKS AM, Vornoli A, Kovi RC, Ton TVT, et al
    Genetic profiling of rat gliomas and cardiac schwannomas from life-time radiofrequency radiation exposure study using a targeted next-generation sequencing gene panel.
    PLoS One. 2024;19:e0296699.
    >> Share

  7. JUST U, Burtscher H, Jeratsch S, Fischer M, et al
    Proteomic and transcriptomic characterisation of FIA10, a novel murine leukemic cell line that metastasizes into the brain.
    PLoS One. 2024;19:e0295641.
    >> Share


  8. Retraction: MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene.
    PLoS One. 2024;19:e0297950.
    >> Share

  9. WOHLSEIN JC, Meurer M, Morgelin M, Nessler JN, et al
    Neutrophil extracellular traps in CSF and serum of dogs with steroid-responsive meningitis-arteritis.
    PLoS One. 2024;19:e0295268.
    >> Share

  10. DE VILLIERS O, Elliot-Wilson C, Thomas KGF, Semple PL, et al
    Sleep and cognition in South African patients with non-functioning pituitary adenomas.
    PLoS One. 2024;19:e0296387.
    >> Share

  11. ZECHEL C, Loy M, Wegner C, Dahlke E, et al
    Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
    PLoS One. 2024;19:e0291368.
    >> Share

  12. FIVEASH JB, Ye X, Peerboom DM, Mikkelsen T, et al
    Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702.
    PLoS One. 2024;19:e0291128.
    >> Share

  13. PAN C, Bai X, Li N, Zheng N, et al
    PBX3 as a biomarker for the early diagnosis and prediction of prognosis of glioma.
    PLoS One. 2024;19:e0293647.
    >> Share

  14. CHOHAN MO, Flores RA, Wertz C, Jung RE, et al
    "Non-Eloquent" brain regions predict neuropsychological outcome in tumor patients undergoing awake craniotomy.
    PLoS One. 2024;19:e0284261.
    >> Share

  15. STRUBLOVA L, Kepak T, Kuruczova D, Zlamal F, et al
    Socioeconomic status and adiposity in childhood cancer survivors: A cross-sectional retrospective study.
    PLoS One. 2024;19:e0298068.
    >> Share

  16. HASSAN H, Mirza MR, Jabeen A, Alam M, et al
    Yellow scorpion (Buthus sinidicus) venom peptides induce mitochondrial-mediated apoptosis in cervical, prostate and brain tumor cell lines.
    PLoS One. 2024;19:e0296636.
    >> Share

  17. ZOTEVA V, De Meulenaere V, Vanhove C, Leybaert L, et al
    Integrating and optimizing tonabersat in standard glioblastoma therapy: A preclinical study.
    PLoS One. 2024;19:e0300552.
    >> Share

  18. SALAS-GALLARDO GA, Lorea-Hernandez JJ, Robles-Gomez AA, Del Campo CC, et al
    Morphological differentiation of peritumoral brain zone microglia.
    PLoS One. 2024;19:e0297576.
    >> Share

  19. SUN MA, Yao H, Yang Q, Pirozzi CJ, et al
    Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastoma.
    PLoS One. 2024;19:e0299820.
    >> Share

  20. JIN X, Zhu J, Yu H, Shi S, et al
    Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.
    PLoS One. 2024;19:e0298055.
    >> Share

  21. SUN B, Lu W, Yu W, Tian Y, et al
    Prevalence and risk factors of early postoperative seizures in patients with glioma: A protocol for meta-analysis and systematic review.
    PLoS One. 2024;19:e0301443.
    >> Share

  22. WANG L, Wang H, D'Angelo F, Curtin L, et al
    Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm.
    PLoS One. 2024;19:e0299267.
    >> Share

  23. JAMBOR I, Steiner A, Pesola M, Gardberg M, et al
    Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.
    PLoS One. 2024;19:e0296958.
    >> Share

  24. QI Z, Yu H, Chen L, Qu Y, et al
    Analysis and prediction of central nervous system tumor burden in China during 1990-2030.
    PLoS One. 2024;19:e0300390.
    >> Share

    January 2023
  25. ZHANG L, Qu C, Shi C, Wu F, et al
    Association of RNA-modification "writer" genes with prognosis and response to immunotherapy in patients with low-grade glioma.
    PLoS One. 2023;18:e0279119.
    >> Share

  26. JARUTHIEN T, Nantavithya C, Santisukwongchote S, Shuangshoti S, et al
    Postoperative radiotherapy timing, molecular subgroups and treatment outcomes of Thai pediatric patients with medulloblastoma.
    PLoS One. 2023;18:e0271778.
    >> Share

  27. PRUMMER JK, Stein VM, Marti E, Lutterotti A, et al
    Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin.
    PLoS One. 2023;18:e0280864.
    >> Share

  28. EBINA K, Matsui M, Kinoshita M, Saito D, et al
    The effect of damage to the white matter network and premorbid intellectual ability on postoperative verbal short-term memory and functional outcome in patients with brain lesions.
    PLoS One. 2023;18:e0280580.
    >> Share

  29. BLAKSTAD H, Brekke J, Rahman MA, Arnesen VS, et al
    Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions.
    PLoS One. 2023;18:e0281166.
    >> Share

  30. DOUGHERTY J, Harvey K, Liou A, Labella K, et al
    Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.
    PLoS One. 2023;18:e0277305.
    >> Share

  31. STEIDL E, Filipski K, Hattingen E, Steinbach JP, et al
    Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBVmax nor vessel densities correlate between newly diagnosed and progressive glioblastoma.
    PLoS One. 2023;18:e0274400.
    >> Share

  32. ZHENG Z, Hu Y, Ren Y, Mo G, et al
    Correlation between metastatic patterns and age in patients with metastatic primary liver cancer: A population-based study.
    PLoS One. 2023;18:e0267809.
    >> Share

  33. WANIGASEKARA J, Carroll LJ, Cullen PJ, Tiwari B, et al
    Three-Dimensional (3D) in vitro cell culture protocols to enhance glioblastoma research.
    PLoS One. 2023;18:e0276248.
    >> Share

  34. SALANS M, Houri J, Karunamuni R, Hopper A, et al
    The relationship between radiation dose and bevacizumab-related imaging abnormality in patients with brain tumors: A voxel-wise normal tissue complication probability (NTCP) analysis.
    PLoS One. 2023;18:e0279812.
    >> Share

  35. THEAKSTONE AG, Brennan PM, Jenkinson MD, Goodacre R, et al
    Investigating centrifugal filtration of serum-based FTIR spectroscopy for the stratification of brain tumours.
    PLoS One. 2023;18:e0279669.
    >> Share

  36. JAHEDI A, Kumar G, Kannan L, Agarwal T, et al
    Gibbs process distinguishes survival and reveals contact-inhibition genes in Glioblastoma multiforme.
    PLoS One. 2023;18:e0277176.
    >> Share

  37. BJORKNES B, Neye OE, Hamerlik P, Jauffred L, et al
    Immunostaining protocol for infiltrating brain cancer spheroids for light-sheet imaging.
    PLoS One. 2023;18:e0281161.
    >> Share

  38. HAQ MFU, Hussain MZ, Mahjabeen I, Akram Z, et al
    Oncometabolic role of mitochondrial sirtuins in glioma patients.
    PLoS One. 2023;18:e0281840.
    >> Share

  39. BURTON B, Collins K, Brooks J, Marx K, et al
    The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells.
    PLoS One. 2023;18:e0278793.
    >> Share

  40. SANG H, Cho YK, Han K, Koh EH, et al
    Impact of abdominal obesity on the risk of glioma development in patients with diabetes: A nationwide population-based cohort study in Korea.
    PLoS One. 2023;18:e0283023.
    >> Share

  41. SUGITA Y, Takada S, Tanigaki K, Muraki K, et al
    Inhibition of VEGF receptors induces pituitary apoplexy: An experimental study in mice.
    PLoS One. 2023;18:e0279634.
    >> Share

  42. SAILUNAZ K, Bestepe D, Alhajj S, Ozyer T, et al
    Brain tumor detection and segmentation: Interactive framework with a visual interface and feedback facility for dynamically improved accuracy and trust.
    PLoS One. 2023;18:e0284418.
    >> Share

  43. DE GROOT JD, van Dijken BRJ, van der Weide HL, Enting RH, et al
    Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients.
    PLoS One. 2023;18:e0275077.
    >> Share

  44. TUCKER DW, Pangal DJ, Du R, Gogia AS, et al
    Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.
    PLoS One. 2023;18:e0284949.
    >> Share

  45. JUNG M, Jeong Y, Park BJ
    Adaptation of families of adult patients with brain tumor: Partial least squares structural equation modeling.
    PLoS One. 2023;18:e0285677.
    >> Share

  46. DENES A, Bontell TO, Barcheus H, Vega SF, et al
    The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas.
    PLoS One. 2023;18:e0285732.
    >> Share

  47. KIMURA K, Chun JH, Lin YL, Liang YC, et al
    Tetra-O-methyl-nordihydroguaiaretic acid inhibits energy metabolism and synergistically induces anticancer effects with temozolomide on LN229 glioblastoma tumors implanted in mice while preventing obesity in normal mice that consume high-fat diets.
    PLoS One. 2023;18:e0285536.
    >> Share

  48. DADHANIA S, Pakzad-Shahabi L, Mistry S, Williams M, et al
    Triaxial accelerometer-measured physical activity and functional behaviours among people with High Grade Glioma: The BrainWear Study.
    PLoS One. 2023;18:e0285399.
    >> Share

  49. HUANG Z, Li X, Wei B, Yu Y, et al
    Global metabolomics study on the pathogenesis of pediatric medulloblastoma via UPLC- Q/E-MS/MS.
    PLoS One. 2023;18:e0287121.
    >> Share

  50. HALLUNDBAEK L, Hagstrom S, Mathiasen R, Herlin T, et al
    Musculoskeletal misdiagnoses in children with brain tumors: A nationwide, multicenter case-control study.
    PLoS One. 2023;18:e0279549.
    >> Share

  51. NYHOLM L, Zetterling M, Elf K
    Sleep in neurointensive care patients, and patients after brain tumor surgery.
    PLoS One. 2023;18:e0286389.
    >> Share

  52. MISCHKULNIG M, Hopp B, Wadiura LI, Khalaveh F, et al
    Treatment of high-grade glioma patients during the COVID-19 pandemic: Impact on overall survival, tumor size and delay of treatment.
    PLoS One. 2023;18:e0287993.
    >> Share

  53. KUROKAWA R, Kurokawa M, Baba A, Kim J, et al
    Dynamic susceptibility contrast perfusion-weighted and diffusion-weighted magnetic resonance imaging findings in pilocytic astrocytoma and H3.3 and H3.1 variant diffuse midline glioma, H3K27-altered.
    PLoS One. 2023;18:e0288412.
    >> Share

  54. SHEN L, Zhang Y, Wang Q, Qin F, et al
    Feature interaction network based on hierarchical decoupled convolution for 3D medical image segmentation.
    PLoS One. 2023;18:e0288658.
    >> Share

  55. LEE H, Lee JW, Cho HW, Choe YS, et al
    Methionine metabolism and endocrine function of the pituitary gland in patients with suprasellar germinoma.
    PLoS One. 2023;18:e0288528.
    >> Share

  56. MOLYNEAUX K, Laggner C, Vincent J, Brady-Kalnay S, et al
    Small molecule antagonists of PTPmu identified by artificial intelligence-based computational screening block glioma cell migration and growth.
    PLoS One. 2023;18:e0288980.
    >> Share

  57. XIONG J, Wang M, Gao J, Zhou Y, et al
    Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial.
    PLoS One. 2023;18:e0288863.
    >> Share

  58. WANG Y, Wu Y, Li L, Gao J, et al
    GDNF triggers proliferation of rat C6 glioma cells via the NF-kappaB/CXCL1 signaling pathway.
    PLoS One. 2023;18:e0289071.
    >> Share

  59. VERGARA GA, Eugenio GC, Fleury Malheiros SM, Victor EDS, et al
    Higher Mixed lineage Kinase Domain-like protein (MLKL) is associated with worst overall survival in adult-type diffuse glioma patients.
    PLoS One. 2023;18:e0291019.
    >> Share

  60. YU H, Liu M, Zhang X, Ma T, et al
    The effect of tranexamic acid on intraoperative blood loss in patients undergoing brain meningioma resections: Study protocol for a randomized controlled trial.
    PLoS One. 2023;18:e0290725.
    >> Share

  61. NDUOM EK, Glod J, Brown DA, Fagan M, et al
    Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysis.
    PLoS One. 2023;18:e0291068.
    >> Share

  62. WANG C, Li P
    Risk factors for intraoperative blood loss in resection of intracranial meningioma: Analysis of 530 cases.
    PLoS One. 2023;18:e0291171.
    >> Share


  63. Retraction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
    PLoS One. 2023;18:e0291490.
    >> Share

  64. LI W, Lv D, Yao J, Chen B, et al
    A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma.
    PLoS One. 2023;18:e0291024.
    >> Share

  65. CHOATE KA, Raack EJ, Line VF, Jennings MJ, et al
    Rapid extraction-free detection of the R132H isocitrate dehydrogenase mutation in glioma using colorimetric peptide nucleic acid-loop mediated isothermal amplification (CPNA-LAMP).
    PLoS One. 2023;18:e0291666.
    >> Share

  66. ULLAH N, Javed A, Alhazmi A, Hasnain SM, et al
    TumorDetNet: A unified deep learning model for brain tumor detection and classification.
    PLoS One. 2023;18:e0291200.
    >> Share

  67. GLOBUS O, Sagie S, Lavine N, Barchana DI, et al
    Early death after a diagnosis of metastatic solid cancer-raising awareness and identifying risk factors from the SEER database.
    PLoS One. 2023;18:e0281561.
    >> Share

  68. LE MK, Vuong HG, Dunn IF, Kondo T, et al
    Molecular and clinicopathological implications of PRAME expression in adult glioma.
    PLoS One. 2023;18:e0290542.
    >> Share

  69. SAKOWITZ S, Bakhtiyar SS, Mallick S, Khoraminejad B, et al
    Decreasing rates of colectomy for benign neoplasms: A nationwide analysis.
    PLoS One. 2023;18:e0293389.
    >> Share

  70. SUHAIL M, Tarique M, Tabrez S, Zughaibi TA, et al
    Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics.
    PLoS One. 2023;18:e0293666.
    >> Share

  71. BONERT M, Berzins A, Begum H, Schittenhelm J, et al
    Neuroanatomical location of brain metastases from solid tumours based on pathology: An analysis of 511 patients with a comparison to the provided clinical history.
    PLoS One. 2023;18:e0294154.
    >> Share

  72. GAO X, Zhang F, Zhou Q, Xu H, et al
    Metastasis, characteristic, and treatment of breast cancer in young women and older women: A study from the Surveillance, Epidemiology, and End Results registration database.
    PLoS One. 2023;18:e0293830.
    >> Share

  73. ANTTONEN J, Remes T, Arikoski P, Lahteenmaki P, et al
    Correction: Pre- and postdiagnosis growth failure, adult short stature, and untreated growth hormone deficiency in radiotherapy-treated long-term survivors of childhood brain tumor.
    PLoS One. 2023;18:e0294792.
    >> Share

  74. NASSANI R, Bokhari Y, Alrfaei BM
    Molecular signature to predict quality of life and survival with glioblastoma using Multiview omics model.
    PLoS One. 2023;18:e0287448.
    >> Share

  75. VERISSIMO DCA, Camillo-Andrade AC, Santos MDM, Sprengel SL, et al
    Proteomics reveals differentially regulated pathways when comparing grade 2 and 4 astrocytomas.
    PLoS One. 2023;18:e0290087.
    >> Share

  76. YOON HG, Cheong JH, Ryu JI, Won YD, et al
    The genes significantly associated with an improved prognosis and long-term survival of glioblastoma.
    PLoS One. 2023;18:e0295061.
    >> Share

  77. MAKRANZ C, Lubotzky A, Zemmour H, Shemer R, et al
    Short report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study.
    PLoS One. 2023;18:e0285646.
    >> Share

  78. KAHOLONGO NO, Mashingaidze-Mano R
    Paediatric cancer burden in Namibia: A 10-year retrospective, analytical cohort study of patients admitted at Windhoek Central Hospital.
    PLoS One. 2023;18:e0292794.
    >> Share

  79. FAN ST, Xu HQ, He Y, Tu MX, et al
    Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses.
    PLoS One. 2023;18:e0294144.
    >> Share

  80. URCUYO JC, Curtin L, Langworthy JM, De Leon G, et al
    Image-localized biopsy mapping of brain tumor heterogeneity: A single-center study protocol.
    PLoS One. 2023;18:e0287767.
    >> Share

  81. HONG CS, Smith TR
    Aerobic exercise interventions to address impaired quality of life in patients with pituitary tumors.
    PLoS One. 2023;18:e0295907.
    >> Share

    January 2022
  82. WU C, Zhong J, Lin L, Chen Y, et al
    Segmentation of HE-stained meningioma pathological images based on pseudo-labels.
    PLoS One. 2022;17:e0263006.
    >> Share

  83. JAVIER R, Wang W, Drumm M, McCortney K, et al
    The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma.
    PLoS One. 2022;17:e0257725.
    >> Share

  84. VILLATORO AJ, Alcoholado C, Martin-Astorga MDC, Rubio N, et al
    Suicide gene therapy by canine mesenchymal stem cell transduced with thymidine kinase in a u-87 glioblastoma murine model: Secretory profile and antitumor activity.
    PLoS One. 2022;17:e0264001.
    >> Share

  85. POWER EA, Fernandez-Torres J, Zhang L, Yaun R, et al
    Chorioallantoic membrane (CAM) assay to study treatment effects in diffuse intrinsic pontine glioma.
    PLoS One. 2022;17:e0263822.
    >> Share

  86. VAN DIJKEN BRJ, Ankrah AO, Stormezand GN, Dierckx RAJO, et al
    Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma.
    PLoS One. 2022;17:e0264387.
    >> Share

  87. ZHANG H, Zhu S, Xing Y, Liu Q, et al
    Effect of cryopreservation on A172 and U251 glioma cells infected with lentiviral vectors designed for CRISPR/Cas9-mediated aquaporin-8 knock-out.
    PLoS One. 2022;17:e0263162.
    >> Share

  88. FITT B, Loy G, Christopher E, Brennan PM, et al
    Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review.
    PLoS One. 2022;17:e0264740.
    >> Share

  89. VERYASKINA YA, Titov SE, Ivanov MK, Ruzankin PS, et al
    Selection of reference genes for quantitative analysis of microRNA expression in three different types of cancer.
    PLoS One. 2022;17:e0254304.
    >> Share

  90. PARK YJ, Lee JW, Cho HW, Choe YS, et al
    Value of C-11 methionine PET/CT in patients with intracranial germinoma.
    PLoS One. 2022;17:e0263690.
    >> Share

  91. BEAUMONT J, Gambarota G, Prior M, Fripp J, et al
    Avoiding data loss: Synthetic MRIs generated from diffusion imaging can replace corrupted structural acquisitions for freesurfer-seeded tractography.
    PLoS One. 2022;17:e0247343.
    >> Share

  92. WILLIAMS G, Llewelyn A, Thatcher R, Hardisty KM, et al
    Utilisation of semiconductor sequencing for the detection of predictive biomarkers in glioblastoma.
    PLoS One. 2022;17:e0245817.
    >> Share

  93. COLLI SL, Cardoso N, Massone CA, Cores M, et al
    Molecular alterations in the integrated diagnosis of pediatric glial and glioneuronal tumors: A single center experience.
    PLoS One. 2022;17:e0266466.
    >> Share

  94. SEKI Y, Ichihara A
    Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors.
    PLoS One. 2022;17:e0267324.
    >> Share

  95. KANG YM, Lee YY, Lin SC, Chang FC, et al
    Bifocal lesions have a poorer treatment outcome than a single lesion in adult patients with intracranial germinoma.
    PLoS One. 2022;17:e0264641.
    >> Share


  96. Retraction: Secreted Frizzled-Related Protein 4 Inhibits Glioma Stem-Like Cells by Reversing Epithelial to Mesenchymal Transition, Inducing Apoptosis and Decreasing Cancer Stem Cell Properties.
    PLoS One. 2022;17:e0268372.
    >> Share


  97. Retraction: Enhanced Anti-Tumor Effect of Zoledronic Acid Combined with Temozolomide against Human Malignant Glioma Cell Expressing O6-Methylguanine DNA Methyltransferase.
    PLoS One. 2022;17:e0268315.
    >> Share

  98. KARRI R, Chen YP, Drummond KJ
    Using machine learning to predict health-related quality of life outcomes in patients with low grade glioma, meningioma, and acoustic neuroma.
    PLoS One. 2022;17:e0267931.
    >> Share

  99. LUGTU EJ, Ramos DB, Agpalza AJ, Cabral EA, et al
    Artificial neural network in the discrimination of lung cancer based on infrared spectroscopy.
    PLoS One. 2022;17:e0268329.
    >> Share


  100. Retraction: BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells.
    PLoS One. 2022;17:e0270174.
    >> Share

  101. MAO DD, Cleary RT, Gujar A, Mahlokozera T, et al
    CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells.
    PLoS One. 2022;17:e0270251.
    >> Share

  102. REN J, Da J, Hu N
    Identification of COL1A1 associated with immune infiltration in brain lower grade glioma.
    PLoS One. 2022;17:e0269533.
    >> Share

  103. TUNTHANATHIP T, Sae-Heng S, Oearsakul T, Kaewborisutsakul A, et al
    Economic impact of a machine learning-based strategy for preparation of blood products in brain tumor surgery.
    PLoS One. 2022;17:e0270916.
    >> Share

  104. THAKUR JD, Mallari RJ, Corlin A, Yawitz S, et al
    Critical appraisal of minimally invasive keyhole surgery for intracranial meningioma in a large case series.
    PLoS One. 2022;17:e0264053.
    >> Share

  105. RIGTER LS, Snaebjornsson P, Rosenberg EH, Altena E, et al
    Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer.
    PLoS One. 2022;17:e0270591.
    >> Share

  106. VASSILIEVA A, Moller K, Skjoth-Rasmussen J, Sorensen MK, et al
    Hyperlactatemia associated with elective tumor craniotomy: Protocol for an observational study of pathophysiology and clinical implications.
    PLoS One. 2022;17:e0271682.
    >> Share

  107. PAUL DA, Rodrigue A, Contento N, Haber S, et al
    Prolactin at moderately increased levels confers a neuroprotective effect in non-secreting pituitary macroadenomas.
    PLoS One. 2022;17:e0271690.
    >> Share

  108. ELMTALAB S, Abedi I, Alirezaei Z, Choopan Dastjerdi MH, et al
    Semi-experimental assessment of neutron equivalent dose and secondary cancer risk for off-field organs in glioma patients undergoing 18-MV radiotherapy.
    PLoS One. 2022;17:e0271028.
    >> Share

  109. BUCHLAK QD, Esmaili N, Bennett C, Wang YY, et al
    Predictors of improvement in quality of life at 12-month follow-up in patients undergoing anterior endoscopic skull base surgery.
    PLoS One. 2022;17:e0272147.
    >> Share

  110. GULDAGER R, Loft MI, Nordentoft S, Aadal L, et al
    Facilitators and barriers of relatives' involvement in nursing care decisions and self-care of patients with acquired brain injury or malignant brain tumour: A scoping review protocol.
    PLoS One. 2022;17:e0273151.
    >> Share

  111. LASICA N, Djilvesi D, Papic V, Karan M, et al
    Venous thromboembolic and hemorrhagic events after meningioma surgery: A single-center retrospective cohort study of risk factors.
    PLoS One. 2022;17:e0273189.
    >> Share

  112. HATTORI Y, Kurozumi K, Otani Y, Uneda A, et al
    Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis.
    PLoS One. 2022;17:e0273242.
    >> Share

  113. ACQUARELLI J, van Laarhoven T, Postma GJ, Jansen JJ, et al
    Convolutional neural networks to predict brain tumor grades and Alzheimer's disease with MR spectroscopic imaging data.
    PLoS One. 2022;17:e0268881.
    >> Share

  114. PECULIS R, Rovite V, Megnis K, Balcere I, et al
    Whole exome sequencing reveals novel risk genes of pituitary neuroendocrine tumors.
    PLoS One. 2022;17:e0265306.
    >> Share

  115. KUZNICKI ML, Mallen A, Ha K, McClung EC, et al
    Prognostic features of endometrial cancer metastasis to the central nervous system.
    PLoS One. 2022;17:e0268794.
    >> Share

  116. ANTTONEN J, Remes T, Arikoski P, Lahteenmaki P, et al
    Pre- and postdiagnosis growth failure, adult short stature, and untreated growth hormone deficiency in radiotherapy-treated long-term survivors of childhood brain tumor.
    PLoS One. 2022;17:e0274274.
    >> Share

  117. REIGSTAD A, Herdlevaer CF, Rigg E, Hoang T, et al
    CCT196969 effectively inhibits growth and survival of melanoma brain metastasis cells.
    PLoS One. 2022;17:e0273711.
    >> Share

  118. GUNES S, He Z, Tsoukou E, Ng SW, et al
    Cell death induced in glioblastoma cells by Plasma-Activated-Liquids (PAL) is primarily mediated by membrane lipid peroxidation and not ROS influx.
    PLoS One. 2022;17:e0274524.
    >> Share

  119. SHIM YB, Byun JY, Lee JY, Lee EK, et al
    Economic burden of brain metastases in non-small cell lung cancer patients in South Korea: A retrospective cohort study using nationwide claims data.
    PLoS One. 2022;17:e0274876.
    >> Share

  120. SCHADEWALDT V, Cherkil S, Panikar D, Drummond KJ, et al
    Quality of life after resection of a meningioma-A cross-cultural comparison of Indian and Australian patients.
    PLoS One. 2022;17:e0275184.
    >> Share

  121. SHEN L, Li Y, Li N, Shen L, et al
    Comprehensive analyses reveal the role of histone deacetylase genes in prognosis and immune response in low-grade glioma.
    PLoS One. 2022;17:e0276120.
    >> Share

  122. ROQUES M, Catalaa I, Raveneau M, Attal J, et al
    Assessment of the hypervascularized fraction of glioblastomas using a volume analysis of dynamic susceptibility contrast-enhanced MRI may help to identify pseudoprogression.
    PLoS One. 2022;17:e0270216.
    >> Share

  123. TAN SC, Low TY, Hussain HMJ, Sharzehan MAK, et al
    Association between XRCC3 p.Thr241Met polymorphism and risk of glioma: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0276313.
    >> Share

  124. WON SY, Lee JH, Lee N, Park YW, et al
    Three-dimensional fractal dimension and lacunarity features may noninvasively predict TERT promoter mutation status in grade 2 meningiomas.
    PLoS One. 2022;17:e0276342.
    >> Share

  125. DUSSEL V, Orellana L, Holder R, Porth R, et al
    A multisite randomized controlled trial of an early palliative care intervention in children with advanced cancer: The PediQUEST Response Study Protocol.
    PLoS One. 2022;17:e0277212.
    >> Share

  126. SUNDBLOM J, Skare TP, Holm O, Welin S, et al
    Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels.
    PLoS One. 2022;17:e0278166.
    >> Share

  127. FERNANDEZ-GALLARDO M, Corzo-Lopez A, Munoz-Herrera D, Leyva-Leyva M, et al
    Role of the Ca2+ channel alpha2delta-1 auxiliary subunit in proliferation and migration of human glioblastoma cells.
    PLoS One. 2022;17:e0279186.
    >> Share

  128. GERRITSEN JKW, Rizopoulos D, Schouten JW, Haitsma IK, et al
    Impact of dedicated neuro-anesthesia management on clinical outcomes in glioblastoma patients: A single-institution cohort study.
    PLoS One. 2022;17:e0278864.
    >> Share

    January 2021
  129. WHITE ML, Zhang Y, Kazmi SAJ, Aizenberg M, et al
    Evaluating survival in subjects with astrocytic brain tumors by dynamic susceptibility-weighted perfusion MR imaging.
    PLoS One. 2021;16:e0244275.
    >> Share

  130. SHI H, Song Y, Song Z, Huang C, et al
    CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma.
    PLoS One. 2021;16:e0245524.
    >> Share

  131. ZHAO Y, Zhang X, Yao J
    Comprehensive analysis of PLOD family members in low-grade gliomas using bioinformatics methods.
    PLoS One. 2021;16:e0246097.
    >> Share

  132. LIM J, Park Y, Ahn JW, Hwang SJ, et al
    Maximal surgical resection and adjuvant surgical technique to prolong the survival of adult patients with thalamic glioblastoma.
    PLoS One. 2021;16:e0244325.
    >> Share

  133. YU VY, Nguyen D, O'Connor D, Ruan D, et al
    Treating Glioblastoma Multiforme (GBM) with super hyperfractionated radiation therapy: Implication of temporal dose fractionation optimization including cancer stem cell dynamics.
    PLoS One. 2021;16:e0245676.
    >> Share

  134. ALI S, Borin TF, Piranlioglu R, Ara R, et al
    Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study.
    PLoS One. 2021;16:e0246646.
    >> Share

  135. JUNG HW, Kim HY, Kim JY, Cheon JE, et al
    Cardiac autonomic dysfunction is associated with hypothalamic damage in patients with childhood-onset craniopharyngioma.
    PLoS One. 2021;16:e0246789.
    >> Share

  136. CAVATORTA C, Meroni S, Montin E, Oprandi MC, et al
    Retrospective study of late radiation-induced damages after focal radiotherapy for childhood brain tumors.
    PLoS One. 2021;16:e0247748.
    >> Share

  137. JIANG Z, Shi Y, Tan G, Wang Z, et al
    Computational screening of potential glioma-related genes and drugs based on analysis of GEO dataset and text mining.
    PLoS One. 2021;16:e0247612.
    >> Share

  138. BOLCAEN J, Descamps B, Deblaere K, De Vos F, et al
    Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI.
    PLoS One. 2021;16:e0248193.
    >> Share

  139. LAMMER F, Delbridge C, Wurstle S, Neff F, et al
    Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.
    PLoS One. 2021;16:e0248612.
    >> Share

  140. LIM J, Park Y, Ahn JW, Sim J, et al
    Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial.
    PLoS One. 2021;16:e0247293.
    >> Share

  141. YE ZP, He HY, Wang H, Li WS, et al
    Retraction: Glioma-Derived ADAM10 Induces Regulatory B Cells to Suppress CD8+ T Cells.
    PLoS One. 2021;16:e0249104.
    >> Share

  142. CAO Y, Yang R, Lee I, Zhang W, et al
    Prediction of LncRNA-encoded small peptides in glioma and oligomer channel functional analysis using in silico approaches.
    PLoS One. 2021;16:e0248634.
    >> Share


  143. Correction: Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
    PLoS One. 2021;16:e0250189.
    >> Share

  144. PROST DM, Merenzon MA, Gomez-Escalante JI, Primavera A, et al
    Effects of time to chemoradiation on high-grade gliomas from the Buenos Aires Metropolitan Area.
    PLoS One. 2021;16:e0249486.
    >> Share

  145. GIHR G, Horvath-Rizea D, Hekeler E, Ganslandt O, et al
    Diffusion weighted imaging in high-grade gliomas: A histogram-based analysis of apparent diffusion coefficient profile.
    PLoS One. 2021;16:e0249878.
    >> Share

  146. NONAKA M, Mabashi-Asazuma H, Jarvis DL, Yamasaki K, et al
    Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.
    PLoS One. 2021;16:e0241157.
    >> Share

  147. WANG L, Liu Y, Xuan C, Liu Y, et al
    Identification of ubiquitination-related genes in human glioma as indicators of patient prognosis.
    PLoS One. 2021;16:e0250239.
    >> Share

  148. WILLIFORD SE, Libby CJ, Ayokanmbi A, Otamias A, et al
    Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells.
    PLoS One. 2021;16:e0250649.
    >> Share


  149. Correction: Three-dimensional visualization of brain tumor progression based accurate segmentation via comparative holographic projection.
    PLoS One. 2021;16:e0251614.
    >> Share

  150. SHIN C, Kim JM, Cheong JH, Ryu JI, et al
    Association between tumor size and peritumoral brain edema in patients with convexity and parasagittal meningiomas.
    PLoS One. 2021;16:e0252945.
    >> Share

  151. DORRELL MI, Kast-Woelbern HR, Botts RT, Bravo SA, et al
    A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis.
    PLoS One. 2021;16:e0252233.
    >> Share

  152. GARRETT C, Becker TM, Lynch D, Po J, et al
    Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
    PLoS One. 2021;16:e0252614.
    >> Share

  153. ROY S, Maji P
    Multispectral co-occurrence of wavelet coefficients for malignancy assessment of brain tumors.
    PLoS One. 2021;16:e0250964.
    >> Share

  154. LIU H, Chen C, Zeng J, Zhao Z, et al
    MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells.
    PLoS One. 2021;16:e0253522.
    >> Share

  155. FUCHS J, Fruh M, Papachristofilou A, Bubendorf L, et al
    Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients - evaluation of outcome and prognostic factors: A retrospective multicenter study.
    PLoS One. 2021;16:e0253601.
    >> Share

  156. LEE S, Choi SH, Cho HR, Koh J, et al
    Multiparametric magnetic resonance imaging features of a canine glioblastoma model.
    PLoS One. 2021;16:e0254448.
    >> Share

  157. JOHANN P, Lenz D, Ries M
    The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug Product designation database.
    PLoS One. 2021;16:e0252924.
    >> Share

  158. HEYDASCH U, Kessler R, Warnke JP, Eschrich K, et al
    Functional diversity of PFKFB3 splice variants in glioblastomas.
    PLoS One. 2021;16:e0241092.
    >> Share

  159. CHANG LS, Oblinger JL, Smith AE, Ferrer M, et al
    Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.
    PLoS One. 2021;16:e0252048.
    >> Share

  160. ALENDA C, Rojas E, Valor LM
    FFPE samples from cavitational ultrasonic surgical aspirates are suitable for RNA profiling of gliomas.
    PLoS One. 2021;16:e0255168.
    >> Share

  161. CHANG FC, Wong TT, Wu KS, Lu CF, et al
    Magnetic resonance radiomics features and prognosticators in different molecular subtypes of pediatric Medulloblastoma.
    PLoS One. 2021;16:e0255500.
    >> Share

  162. MALLARI RJ, Avery MB, Corlin A, Eisenberg A, et al
    Streamlining brain tumor surgery care during the COVID-19 pandemic: A case-control study.
    PLoS One. 2021;16:e0254958.
    >> Share

  163. HUANG YH, Wu ZF, Lee MS, Lou YS, et al
    Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in glioblastoma surgery.
    PLoS One. 2021;16:e0255627.
    >> Share

  164. BANAN R, Akbarian A, Samii M, Samii A, et al
    Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures.
    PLoS One. 2021;16:e0249647.
    >> Share

  165. LUO EW, Liao ML, Chien CL
    Neural differentiation of glioblastoma cell lines via a herpes simplex virus thymidine kinase/ganciclovir system driven by a glial fibrillary acidic protein promoter.
    PLoS One. 2021;16:e0253008.
    >> Share

  166. MOHAMMADI E, Ghasemi E, Azadnajafabad S, Rezaei N, et al
    A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017.
    PLoS One. 2021;16:e0247120.
    >> Share

  167. KUO CY, Lee CC, Lee YL, Liou SC, et al
    Visual light perceptions caused by medical linear accelerator: Findings of machine-learning algorithms in a prospective questionnaire-based case-control study.
    PLoS One. 2021;16:e0247597.
    >> Share

  168. KWON HJ, Oh YT, Park S, Kim SS, et al
    Analysis of electric cigarette liquid effect on mouse brain tumor growth through EGFR and ERK activation.
    PLoS One. 2021;16:e0256730.
    >> Share

  169. JAIN S, Mazaheri B, Raviv N, Bruck J, et al
    Glioblastoma signature in the DNA of blood-derived cells.
    PLoS One. 2021;16:e0256831.
    >> Share

  170. LEE SH, Kwon HJ, Park S, Kim CI, et al
    Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
    PLoS One. 2021;16:e0257375.
    >> Share

  171. BOWLES EJA, Miglioretti DL, Kwan ML, Bartels U, et al
    Long-term medical imaging use in children with central nervous system tumors.
    PLoS One. 2021;16:e0248643.
    >> Share

  172. NAYAK C, Singh SK
    In silico identification of natural product inhibitors against Octamer-binding transcription factor 4 (Oct4) to impede the mechanism of glioma stem cells.
    PLoS One. 2021;16:e0255803.
    >> Share

  173. MINH DUC N
    The diagnostic function of intravoxel incoherent motion for distinguishing between pilocytic astrocytoma and ependymoma.
    PLoS One. 2021;16:e0247899.
    >> Share

  174. STANIC D, Grujicic D, Pekmezovic T, Bokun J, et al
    Clinical profile, treatment and outcome of pediatric brain tumors in Serbia in a 10-year period: A national referral institution experience.
    PLoS One. 2021;16:e0259095.
    >> Share

  175. BENNEBROEK CAM, Wijninga LE, Limpens J, Schouten-van Meeteren AYN, et al
    Impact of systemic anticancer therapy in pediatric optic pathway glioma on visual function: A systematic review.
    PLoS One. 2021;16:e0258548.
    >> Share

  176. SEOMUN G, Lee J, Park J
    Exposure to extremely low-frequency magnetic fields and childhood cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251628.
    >> Share

  177. MELO SM, Marta GN, Latorraca COC, Martins CB, et al
    Hypofractionated radiotherapy for newly diagnosed elderly glioblastoma patients: A systematic review and network meta-analysis.
    PLoS One. 2021;16:e0257384.
    >> Share

  178. SERRA R, Zhao T, Huq S, Gorelick NL, et al
    Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model.
    PLoS One. 2021;16:e0251957.
    >> Share

  179. TAKASHIMA Y, Kawaguchi A, Fukai J, Iwadate Y, et al
    Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.
    PLoS One. 2021;16:e0251272.
    >> Share

  180. ZHANG Q, Yun KK, Wang H, Yoon SW, et al
    Automatic cell counting from stimulated Raman imaging using deep learning.
    PLoS One. 2021;16:e0254586.
    >> Share

  181. RANA R, Rathi V, Chauhan K, Jain K, et al
    Exploring the role of epidermal growth factor receptor variant III in meningeal tumors.
    PLoS One. 2021;16:e0255133.
    >> Share

  182. VERES G, Vas NF, Lyngby Lassen M, Beresova M, et al
    Effect of grey-level discretization on texture feature on different weighted MRI images of diverse disease groups.
    PLoS One. 2021;16:e0253419.
    >> Share

  183. YAN JL, Chang CN, Chen PY
    Endoscopic transsphenoidal surgery for resection of pituitary macroadenoma: A retrospective study.
    PLoS One. 2021;16:e0255599.
    >> Share

  184. WU Q, Yin X, Zhao W, Xu W, et al
    Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt/beta-catenin signaling.
    PLoS One. 2021;16:e0260864.
    >> Share

  185. CONIGLIO SJ, Segall JE
    Microglial-stimulation of glioma invasion involves the EGFR ligand amphiregulin.
    PLoS One. 2021;16:e0260252.
    >> Share

  186. LIU Y, Liu Y, Gao Y, Wang L, et al
    H19- and hsa-miR-338-3p-mediated NRP1 expression is an independent predictor of poor prognosis in glioblastoma.
    PLoS One. 2021;16:e0260103.
    >> Share

  187. NUIJTS MA, Imhof SM, Veldhuis N, Dekkers CC, et al
    The diagnostic accuracy and prognostic value of OCT for the evaluation of the visual function in children with a brain tumour: A systematic review.
    PLoS One. 2021;16:e0261631.
    >> Share

  188. CHOI SS, Choi H, Baek IC, Park SA, et al
    HLA polymorphisms and risk of glioblastoma in Koreans.
    PLoS One. 2021;16:e0260618.
    >> Share

  189. AN C, Park YW, Ahn SS, Han K, et al
    Radiomics machine learning study with a small sample size: Single random training-test set split may lead to unreliable results.
    PLoS One. 2021;16:e0256152.
    >> Share

  190. CENNAMO G, Solari D, Montorio D, Scala MR, et al
    The role of OCT- angiography in predicting anatomical and functional recovery after endoscopic endonasal pituitary surgery: A 1-year longitudinal study.
    PLoS One. 2021;16:e0260029.
    >> Share

    January 2020
  191. NUIJTS MA, Veldhuis N, Stegeman I, van Santen HM, et al
    Visual functions in children with craniopharyngioma at diagnosis: A systematic review.
    PLoS One. 2020;15:e0240016.
    >> Share

  192. CRANE AT, Chrostek MR, Krishna VD, Shiao M, et al
    Zika virus-based immunotherapy enhances long-term survival of rodents with brain tumors through upregulation of memory T-cells.
    PLoS One. 2020;15:e0232858.
    >> Share

  193. WENINGER L, Na CH, Jutten K, Merhof D, et al
    Analyzing the effects of free water modeling by deep learning on diffusion MRI structural connectivity estimates in glioma patients.
    PLoS One. 2020;15:e0239475.
    >> Share

  194. CHELEBIAN E, Fuster-Garcia E, Alvarez-Torres MDM, Juan-Albarracin J, et al
    Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype.
    PLoS One. 2020;15:e0232500.
    >> Share

  195. ZHANG J, Li YI, Pieters TA, Towner J, et al
    Sepsis and septic shock after craniotomy: Predicting a significant patient safety and quality outcome measure.
    PLoS One. 2020;15:e0235273.
    >> Share

  196. GUERREIRO EM, Ovstebo R, Thiede B, Costea DE, et al
    Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics.
    PLoS One. 2020;15:e0238591.
    >> Share

  197. TAN TH, Chen D, Soon YY, Chee Seong Tey J, et al
    Quality of reporting of cranial irradiation techniques in randomized controlled trials of primary brain tumors: A systematic review.
    PLoS One. 2020;15:e0241566.
    >> Share

  198. HUANG J, Milchenko M, Rao YJ, LaMontagne P, et al
    A feasibility study to evaluate early treatment response of brain metastases one week after stereotactic radiosurgery using perfusion weighted imaging.
    PLoS One. 2020;15:e0241835.
    >> Share

  199. CHO JH, Lim YC, Han KD, Lee JY, et al
    The incidence of malignant brain tumors is increased in patients with obstructive sleep apnea: A national health insurance survey.
    PLoS One. 2020;15:e0241598.
    >> Share

  200. SAADEH FS, Morsi RZ, El-Kurdi A, Nemer G, et al
    Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population.
    PLoS One. 2020;15:e0242793.
    >> Share

  201. HARATI R, Hafezi S, Mabondzo A, Tlili A, et al
    Silencing miR-202-3p increases MMP-1 and promotes a brain invasive phenotype in metastatic breast cancer cells.
    PLoS One. 2020;15:e0239292.
    >> Share

  202. ACHIHA T, Kijima N, Kodama Y, Kagawa N, et al
    Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion.
    PLoS One. 2020;15:e0243272.
    >> Share

  203. DE MEULENAERE V, Descamps B, De Wever O, Vanhove C, et al
    In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis.
    PLoS One. 2020;15:e0243156.
    >> Share

  204. INHESTERN L, Peikert ML, Krauth KA, Escherich G, et al
    Parents' perception of their children's process of reintegration after childhood cancer treatment.
    PLoS One. 2020;15:e0239967.
    >> Share

  205. KRUSEOVA J, Kovacova AS, Zapotocky M, Sumerauer D, et al
    Older age is a protective factor for academic achievements irrespective of treatment modalities for posterior fossa brain tumours in children.
    PLoS One. 2020;15:e0243998.
    >> Share

  206. TOGAO O, Chikui T, Tokumori K, Kami Y, et al
    Gamma distribution model of diffusion MRI for the differentiation of primary central nerve system lymphomas and glioblastomas.
    PLoS One. 2020;15:e0243839.
    >> Share

  207. CENNAMO G, Solari D, Montorio D, Scala MR, et al
    Early vascular modifications after endoscopic endonasal pituitary surgery: The role of OCT-angiography.
    PLoS One. 2020;15:e0241295.
    >> Share

  208. WU B, Jiang S, Wang X, Zhong S, et al
    Identification of driver genes and key pathways of non-functional pituitary adenomas predicts the therapeutic effect of STO-609.
    PLoS One. 2020;15:e0240230.
    >> Share

  209. WANG JL, Barth RF, Cavaliere R, Puduvalli VK, et al
    Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas.
    PLoS One. 2020;15:e0244383.
    >> Share

  210. DURMO F, Rydhog A, Testud F, Latt J, et al
    Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
    PLoS One. 2020;15:e0244003.
    >> Share

  211. YOUNES ST, Herrington B
    In silico analysis identifies a putative cell-of-origin for BRAF fusion-positive cerebellar pilocytic astrocytoma.
    PLoS One. 2020;15:e0242521.
    >> Share

  212. CHEN T, Ren Y, Wang C, Huang B, et al
    Risk factors for hydrocephalus following fourth ventricle tumor surgery: A retrospective analysis of 121 patients.
    PLoS One. 2020;15:e0241853.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016